IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news ...

Tearful loved ones said farewell to “beautiful” Anne Terese McPhee after her death at 46. One onlooker said: “It was a moving and unusual sight to see those beautiful white horses moving ...

Don’t forget to stock up on an everyday bodysuit that pairs well with a versatile mix of items in your closet. Of course, you can opt for more popular (and expensive) picks on the market ...

Glenn Close, 77, is an Emmy- and Tony-winning actress best known for her roles in the films “Fatal Attraction,” “Dangerous Liaisons” and “The Wife.” She co-stars in the Netflix film ...

Ah, the scorpion lollipop, a symbol of the Sonoran Desert. I like them, if only for the campiness of the dark, goth-looking scorpion encased unhappily in a gentle green, pink or blue. That said, ...

Eli Lilly has agreed to acquire Scorpion Therapeutics’ breast cancer treatment program for up to $2.5 billion in cash. The drugmaker said Monday it is acquiring Scorpion and its STX-478 program ...

Eli Lilly is reenergizing its attempt to challenge Novartis and Roche for a breast cancer market, kicking off the J.P. Morgan Healthcare Conference with a deal to buy Scorpion Therapeutics ...

We look forward to leveraging the great work of the Scorpion team to date, along with Lilly's deep expertise in breast cancer, to further advance STX-478 with speed and focus." Under the terms of ...

Enter our grandson Tommaso—Tommaso McPhee, whose parents are Luca Passaleva, of Tuscany, and Jenny McPhee. Tommaso is an optical physicist who wrote his undergraduate thesis in optics and has ...

Jan 13 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it plans to buy Scorpion Therapeutics' experimental cancer therapy for up to $2.5 billion in cash to expand its pipeline of ...

SAN FRANCISCO — Eli Lilly said Monday it would acquire a cancer program from startup Scorpion Therapeutics in a deal worth up to $2.5 billion, as the Indianapolis company broadens its pipeline.

Eli Lilly has turned to a biotechnology startup for help building its pipeline of cancer drugs, agreeing on Monday to purchase an experimental cancer drug from privately held Scorpion Therapeutics for ...